Bausch + Lomb (BLCO) revenue

Revenue · fiscal 2025
$5.10B

Bausch + Lomb (BLCO) reported revenue of $5.10B in fiscal 2025 (the year ended December 31, 2025). That is 6.5% higher than the $4.79B of fiscal 2024. Figures as of 18 Nov 2026, 10:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$5.10B
Change on fiscal 2024
+6.5%
Growth, 5 years
+8.4% a year
Highest on record
$5.10Bfiscal 2025
Lowest on record
$3.41Bfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Bausch + Lomb revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 8.4% a year. Across the 6 fiscal years on record (2020–2025), the highest was $5.10B in fiscal 2025 and the lowest $3.41B in fiscal 2020.

History · 6 fiscal years

Revenue by fiscal year

Bausch + Lomb revenue, year by year

Bausch + Lomb (BLCO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$5.10B 6.5% up
2024$4.79B 15.6% up
2023$4.15B 10.0% up
2022$3.77B 0.1% up
2021$3.77B 10.3% up
2020$3.41B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Bausch + Lomb and comparable companies
CompanyRevenueFiscal year
ImmunityBio IBRX$113.29M2025
Cytokinetics CYTK$88.04M2025
Bausch + Lomb BLCO$5.10B2025
Amneal Pharmaceuticals AMRX$3.02B2025
Caris Life Sciences CAI$812.03M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLCO

Bausch + Lomb, figure by figure

Bausch + Lomb (BLCO) overview: price, valuation and scorecardAll health care companies by market value

Bausch + Lomb revenue: questions and answers

What is Bausch + Lomb's revenue?

Bausch + Lomb (BLCO) reported revenue of $5.10B in fiscal 2025 (the year ended December 31, 2025). That is 6.5% higher than the $4.79B of fiscal 2024.

What is the growth rate of Bausch + Lomb's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 8.4% a year.

What are the highest and lowest revenue figures on record for Bausch + Lomb?

Across the 6 fiscal years on record (2020–2025), the highest was $5.10B in fiscal 2025 and the lowest $3.41B in fiscal 2020.

How is Bausch + Lomb's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Bausch + Lomb it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bausch + Lomb (BLCO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/BLCO/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.